关键词: Cutting balloons arteriovenous fistula arteriovenous graft balloon angioplasty covered stents dialysis hemodialysis paclitaxel-coated balloons restenosis stenosis stent-grafts synthetic graft thrombosis

Mesh : Angioplasty, Balloon Clinical Trials as Topic Coated Materials, Biocompatible / pharmacology Humans Paclitaxel / pharmacology Renal Dialysis Stents

来  源:   DOI:10.1080/17434440.2016.1254548   PDF(Sci-hub)

Abstract:
BACKGROUND: Percutaneous transcatheter balloon angioplasty has evolved to the current mainstay treatment for salvage of dysfunctional dialysis access. Nonetheless, it is frequently associated with recurrent vessel restenosis and the need for multiple repeat treatments in order to maintain hemodynamic patency. Cutting-balloons, covered stents or stent-grafts, and paclitaxel-coated balloons have been extensively tested and investigated with the aim to improve immediate anatomical and long-term clinical results. Areas covered: In the present overview, we discuss the background and appraise relevant medical literature on the aforementioned technologies and provide a more in-depth synthesis of the results of different clinical studies for each device category. We will also discuss the limitations in the mode of action of each group of devices and envision what the future holds for the challenging field of dialysis access interventions. Expert commentary: We propose a good practice algorithm for the treatment of thrombosed or dysfunctional dialysis access.
摘要:
背景:经皮球囊血管成形术已发展成为目前用于挽救功能失调的透析通路的主要治疗方法。尽管如此,它通常与复发性血管再狭窄和需要多次重复治疗以维持血流动力学通畅有关.切割气球,覆膜支架或支架移植物,和紫杉醇涂层的球囊已经过广泛的测试和研究,目的是改善即时解剖学和长期临床结果。涵盖的领域:在本概述中,我们讨论了背景,并评估了上述技术的相关医学文献,并为每个设备类别的不同临床研究结果提供了更深入的综合。我们还将讨论每组设备的行动模式的局限性,并设想未来对透析访问干预这一具有挑战性的领域的影响。专家评论:我们提出了一种用于治疗血栓形成或功能失调的透析通路的良好实践算法。
公众号